Moreover, data of demethylation treatment on the purified T cells from T2D patients demonstrate that the MAP4K4 downregulation is due to enhanced methylation on the MAP4K4 promoter [35]. This evidence concerns the gene MAP4K4 and type 2 diabetes mellitus.